ARS Pharmaceuticals (SPRY) Enterprise Value (2020 - 2026)
ARS Pharmaceuticals' Enterprise Value came in at $652.7 million for Q2 2026, down 56.0% from $1.48 billion a year earlier but up 9.4% from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Enterprise Value (2020 - 2026) Analysis & Trends
For FY2025, ARS Pharmaceuticals' Enterprise Value was $911.74 million, up 26.7% from FY2024.
- Enterprise Value has increased in each of the last three years.
- Going back by year, Enterprise Value was $719.42 million in FY2024 (+139.8%), $299.95 million in FY2023 (+282.0%), $78.53 million in FY2022 (-54.8%) and $173.75 million in FY2021.
- The five-year range for quarterly Enterprise Value is -$130.56 million (Q1 2022) to $1.48 billion (Q2 2025).
- Year-over-year, Enterprise Value increased in five of the last eight quarters, with growth averaging 137.9%.
- The fastest year-over-year change in Enterprise Value over five years came in Q3 2024 (growth of 901.6%), and the weakest in Q2 2026 (a decline of 56.0%).
- Business Quant data shows SPRY's Enterprise Value at $596.38 million (Q1 2026), $911.74 million (Q4 2025) and $705.18 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | ARS Pharmaceuticals | 410.68 Mn | 266.88 Mn | 20.81 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 652.70 Mn |
| Mar 31, 2026 | 596.38 Mn |
| Dec 31, 2025 | 911.74 Mn |
| Sep 30, 2025 | 705.18 Mn |
| Jun 30, 2025 | 1.48 Bn |
| Mar 31, 2025 | 958.77 Mn |
| Dec 31, 2024 | 719.42 Mn |
| Sep 30, 2024 | 1.20 Bn |
| Jun 30, 2024 | 606.26 Mn |
| Mar 31, 2024 | 763.39 Mn |
| Dec 31, 2023 | 299.95 Mn |
| Sep 30, 2023 | 120.21 Mn |
| Jun 30, 2023 | 386.46 Mn |
| Mar 31, 2023 | 350.36 Mn |
| Dec 31, 2022 | 78.53 Mn |
| Sep 30, 2022 | -77.16 Mn |
| Jun 30, 2022 | -108.86 Mn |
| Mar 31, 2022 | -130.56 Mn |
| Dec 31, 2021 | 173.75 Mn |
| Sep 30, 2021 | 49.01 Mn |
API Access
ARS Pharmaceuticals Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();